I know when I talked with my caseworker last month, they were excited and awaiting any word on it.........I read the paperwork that you sign at the doctor's office and it looks encouraging. I know Biogen had okayed me for 2 yrs of Tysabri free until my insurance came thru.......so I'm optimistic......because with my traveling all the time, stopping and starting infusion sites is a real juggling act; there is a lot of paperwork, interviews, dr participation, etc., and am learning some infusion sites insist you use their own doctors, and so on.....so with me, am already having to plan for May somewhere else and call my caseworker as soon as April infusion is done and cancel that site, you get the idea.......this would be a welcome relief for sure............and if Biogen is involved, am sure can work thru the insurance, I think, note I think.....
And yes, Biogen Idec obviously had their ducks in a row. Considering they had hoped to have this approved last year and it was delayed until now - I imagine they had lots going on in the background.
The estimate I saw is Tecfidera will be around $51,000 a year for treatment here in the US. Of course that is NOT what our private insurance companies will pay. This price is in line with the cost of the injectables. Gilenya is the big $$ winner with a cost of $60K a year.
Keep us posted, Sarah.
No one on government programs (medicare, etc) are eligible for this $10
co-pay program. Their only suggestion is to contact MSActive Support.
So, will have to call them and also bounce it off of my neuro in May.
I'll keep everyone posted on what I find out
thanks, am going to go check it out..........wow this is good news,
thanks for sharing